CEF8, Influenza Virus NP (383-391) – 1 mg

Overview

The CEF8, Influenza Virus NP (383-391) peptide is a highly specific HLA-B*3501 restricted epitope derived from the nucleoprotein of the influenza virus. This peptide is crucial for researchers studying immune responses to influenza infections, particularly in relating to HLA-B*3501 presentation. With its high purity and quality, the CEF8 peptide is ideal for various applications including immunological assays, peptide-based vaccines, and diagnostics.

Key Features

• High purity peptide, suitable for in vitro studies
• Specific to HLA-B*3501 restricted immune responses
• Supports vaccine development and diagnostic applications
• Available in a convenient 1 mg format
• Backed by rigorous quality control standards

Specifications

FAQ

What can I use the CEF8 peptide for?

The CEF8 peptide is designed for research focused on immune responses against the influenza virus, particularly those involving HLA-B*3501. It can be used in assays, vaccine development, and diagnostic studies.

How should I store the CEF8 peptide?

For optimal stability, store the CEF8 peptide at -20°C, and avoid repeated freeze-thaw cycles. This will help maintain its integrity for future experiments.

Is this peptide suitable for human use?

The CEF8 peptide is intended for research purposes only and is not approved for human use, as it is strictly for laboratory research and development.

If you’re looking to enhance your research capabilities, consider adding the CEF8, Influenza Virus NP (383-391) peptide to your inventory today. This high-quality peptide can make a significant difference in your studies of influenza virus and its immune responses. Shop now to ensure you have the best tools for your research.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.